The percentage of patient’s 18 years of age and older during the measurement year who were hospitalized and discharged from July 1 of the year prior to the measurement year to June 30 of the measurement year with a diagnosis of acute myocardial infarction (AMI) and who received persistent beta-blocker treatment for six months after discharge.
-
-
1.5 Measure Type1.7 Electronic Clinical Quality Measure (eCQM)1.8 Level Of Analysis1.20 Testing Data Sources
-
1.14 Numerator
Patients who received at least 135 days of treatment with beta-blockers during the 180-day measurement interval.
-
1.15 Denominator
An acute inpatient discharge from July 1 of the year prior to the measurement year through June 30 of the measurement year with any diagnosis of acute myocardial infarction (AMI) on the discharge claim.
-
Exclusions
Any of the following any time during the patient’s history through the end of the continuous enrollment period meet criteria:
- Asthma
- COPD
- Obstructive chronic bronchitis
- Chronic respiratory conditions due to fumes and vapors
- Hypotension, heart block >1 degree or sinus bradycardia
- A medication dispensing event indicative of a history of asthma
- Intolerance or allergy to beta-blocker therapy
Additionally, this measure excludes adults in hospice. It also excludes adults with advanced illness and frailty, as well as Medicare adults 65 years of age and older enrolled in an I-SNP or living long-term in institutional settings.
-
1.13a Data dictionary not attachedNoOLD 1.12 MAT output not attachedAttached
-
Most Recent Endorsement ActivityEndorsed Cardiovascular Fall Cycle 2019Initial EndorsementLast Updated
-
Steward Organization EmailSteward Organization Copyright
© 1999 by the National Committee for Quality Assurance
1100 13th Street, NW, 3rd Floor
Washington, DC 20005
-
-
-
Risk AdjustmentRisk adjustment approachOffRisk adjustment approachOffConceptual model for risk adjustmentOffConceptual model for risk adjustmentOff
-
-
-
6.1.2 Current or Planned Use(s)
-